Study: Nalls, 2014
Population | Ethnicity | Diagnosis | Source | # Cases (% women) | # Controls (% women) | AAO (sd) | AAO range | AAE (sd) | AAE range | Ctrl age (sd) | Ctrl age range | # Polymorphisms |
---|---|---|---|---|---|---|---|---|---|---|---|---|
23andMe.v2 (USA, Europe) | C | self-reported clinical diagnosis | O | 3261 (39%) | 29499 (42%) | 64 (11) | - | - | - | 49 (15) | - | 9,752 |
23andMe.v3 (USA, Europe) | C | self-reported clinical diagnosis | O | 866 (39%) | 32538 (40%) | 64 (11) | - | - | - | 44 (16) | - | 9,852 |
France (IPDGC) | C | UKPDSBB | CL | 985 (41%) | 1984 (33%) | 49 (13) | - | - | - | 74 (5) | - | 9,821 |
France (NeuroX) | C | not provided | CL | 553 | 474 | - | - | - | - | - | - | 27 |
Germany (IPDGC) | C | UKPDSBB | CL, PO | 667 (40%) | 937 (48%) | 56 (12) | - | - | - | 47 (12) | - | 9,646 |
Germany (NeuroX) | C | not provided | CL | 1,044 | 871 | - | - | - | - | - | - | 27 |
Greece (NeuroX) | C | not provided | CL | 944 | 877 | - | - | - | - | - | - | 27 |
Iceland (IPDGC-deCODE) | C | UKPDSBB | CL | 604 (48%) | 4916 (57%) | 62 (12) | - | - | - | 80 (8) | - | 9,406 |
Iceland (CHARGE-AGES-RS) | C | ICD codes, medication | PO | 146 (55%) | 5609 (59%) | 75 (8) | - | - | - | 69 (9) | - | 8,205 |
Netherlands (IPDGC) | C | UKPDSBB | CL, PO | 744 (36%) | 2019 (64%) | 56 (12) | - | - | - | 56 (6) | - | 9,595 |
Netherlands (NeuroX) | C | not provided | CL | 97 | 247 | - | - | - | - | - | - | 27 |
UK (IPDGC) | C | UKPDSBB | CL, PO | 1705 (43%) | 5200 (50%) | 64 (12) | - | - | - | 53 (0) | - | 9,673 |
UK (NeuroX) | C | not provided | CL | 405 | 547 | - | - | - | - | - | - | 27 |
USA (IPDGC-NIA) | C | UKPDSBB | CL | 937 (40%) | 1896 (53%) | 58 (13) | - | - | - | 63 (10) | - | 9,622 |
USA (Ashkenazi) | C | UKPDSBB | CL | 268 (33%) | 178 (57%) | 60 (12) | - | - | - | 70 (9) | - | 9,631 |
USA (HIHG) | C | UKPDSBB | CL | 574 (37%) | 619 (65%) | 57 (12) | - | - | - | 69 (10) | - | 9,723 |
USA (NGRC) | C | UKPDSBB | CL | 1956 (33%) | 1982 (61%) | 59 (12) | - | - | - | 70 (14) | - | 9,938 |
USA (PROGENI-GenePD) | C | UKPDSBB | CL | 828 (40%) | 852 (60%) | 62 (11) | - | - | - | 55 (13) | - | 9,762 |
USA (CHARGE-CHS) | C | self-report, ICD-9, medications | PO | 107 (45%) | 3164 (61%) | 73 (5) | - | - | - | 72 (5) | - | 9,655 |
USA (CHARGE-FHS) | C | UKPDSBB | PO | 60 (42%) | 3889 (55%) | 76 (11) | - | - | - | 64 (12) | - | 9,223 |
USA (NeuroX) | C | not provided | CL | 2,407 | 2,782 | - | - | - | - | - | - | 27 |